TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT06796413

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Loop Resection or Cold-cup biopsy
Description: Loop Resection or cold-cup biopsy of bladder tumor base - thus after the tumor has been resected and the deep muscle specimen needed to be obtained, the Loop Cautery or Lowsley Forceps (for cold-cup biopsy) was used to obtain the deep muscle specimen

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Loop Resection or Cold-cup biopsy
Description: Loop Resection or cold-cup biopsy of bladder tumor base - thus after the tumor has been resected and the deep muscle specimen needed to be obtained, the Loop Cautery or Lowsley Forceps (for cold-cup biopsy) was used to obtain the deep muscle specimen
Study: NCT06792708

Intervention type: DRUG
Intervention: LUMRYZ
Description: Prescribed for narcolepsy in accordance with product label.
Study: NCT06797713

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Esophageal doppler
Description: Fluid/inotrope decisions will be made with parameters such as stroke volume (SV), stroke volume variation (SVV), pulse pressure variation (PVV), systemic vascular resistance (SVR), and cardiac output (CO) on the Doppler monitor screen.

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Conventional method
Description: Fluid therapy is performed by monitoring parameters such as blood pressure, urine output, lactate...
Study: NCT06795438

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Green tea
Description: Green tea tablets 1000mg 1 x per day

Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo control 1 x blinded placebo tablet per day
Study: NCT06796881

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Instrument assisted soft tissue mobilization
Description: The group will undergo Instrument assisted soft tissue mobilization using M2Tblade, applying it for 40-120 seconds until hyperemia occurs. After treatment, ice packs will be applied for 5 minutes to reduce hyperemia. The therapist will ensure comfort through continuous communication and reporting any discomfort.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Myofascial release
Description: The therapist will use a cross-hand release technique to release the lumbar spine, ensuring the patient is prone and suitable. They will lean into the patient to the tissue depth barrier, wait, and follow each release, avoiding force or slipping. The technique will be applied for 5 minutes on each side.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: The conventional exercise program
Description: Patients will undergo a 12-session exercise program for 6 weeks, consisting of straight leg raising, bridging exercise, prone hip extension exercise, and abdominal curl exercise. The exercises will be done 3 sets, 10 repetitions each, with 1 minute rest between each set. The abdominal curl exercises involve supine or hook-lying positions with the lumbar spine neutral, with the patient performing a drawing in maneuver to stabilize the abdominal muscles. The progression involves lifting the shoulders, changing arm positions, and holding a weight or medicine ball. The patient's position is hook-lying, maintaining a neutral spinal position.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: The conventional exercise program
Description: Patients will undergo a 12-session exercise program for 6 weeks, consisting of straight leg raising, bridging exercise, prone hip extension exercise, and abdominal curl exercise. The exercises will be done 3 sets, 10 repetitions each, with 1 minute rest between each set. The abdominal curl exercises involve supine or hook-lying positions with the lumbar spine neutral, with the patient performing a drawing in maneuver to stabilize the abdominal muscles. The progression involves lifting the shoulders, changing arm positions, and holding a weight or medicine ball. The patient's position is hook-lying, maintaining a neutral spinal position.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: The conventional exercise program
Description: Patients will undergo a 12-session exercise program for 6 weeks, consisting of straight leg raising, bridging exercise, prone hip extension exercise, and abdominal curl exercise. The exercises will be done 3 sets, 10 repetitions each, with 1 minute rest between each set. The abdominal curl exercises involve supine or hook-lying positions with the lumbar spine neutral, with the patient performing a drawing in maneuver to stabilize the abdominal muscles. The progression involves lifting the shoulders, changing arm positions, and holding a weight or medicine ball. The patient's position is hook-lying, maintaining a neutral spinal position.
Study: NCT06793449

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: anti-BCMA CAR-T
Description: Autologous BCMA-directed CAR-T cells, infusion intravenously at a target dose of 2.0-4.0 x 10\^6 anti-BCMA CAR+T cells/kg.

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: ASCT
Description: Autologous stem cell infusion
Study: NCT06797336

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PT0253
Description: PT0253 injection.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PT0253
Description: PT0253 injection.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PT0253
Description: PT0253 injection.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PT0253
Description: PT0253 injection.
Study: NCT06793436

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: chest wall blocks
Description: The effects of anterior chest wall blocks (PECS and SAP will be used in this study) performed for postoperative analgesia on pain scores (to be checked with VAS), opioid consumption, length of hospital stay, mobilization time, side effects and complications in the postoperative period will be examined.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: chest wall blocks
Description: The effects of anterior chest wall blocks (PECS and SAP will be used in this study) performed for postoperative analgesia on pain scores (to be checked with VAS), opioid consumption, length of hospital stay, mobilization time, side effects and complications in the postoperative period will be examined.
Study: NCT06795321

Intervention type: PROCEDURE
Intervention: Spinal anesthesia
Description: Patients who preferred spinal anesthesia were included in this group.

Intervention type: PROCEDURE
Intervention: General anesthesia
Description: Patients who preferred spinal anesthesia were included in this group
Study: NCT06796621

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Building Respectful Online Space (BROS)
Description: Session 1 (40 minutes to 50 minutes): Respectful online relationship (Psychoeducation) using face-to-face approach with 40 minutes to 50 minutes online serious game Session 2 (40 minutes to 50 minutes): Navigating the online world (Psychoeducation) using face-to-face approach with 20 to 30 minutes online music therapy Session 3 (40 minutes to 50 minutes): Behaviour specific cognitions and reflection using face-to-face approach

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Healthy diet education program
Description: Session 1 (40 - 50 minutes): Healthy Diet Pyramid (Psychoeducation) using face-to-face approach Session 2 (40 - 50 minutes): Mindful Eating and Healthy Weight Management (Psychoeducation) using face-to-face approach Session 3 (40 - 50 minutes): Healthy Eating Habits for Life (Psychoeducation)using face-to-face approach
Study: NCT05930938

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Xevinapant
Description: Xevinapant is a multi-IAP antagonist that blocks the activity of several IAPs including X-linked IAP (XIAP), cellular inhibitor of apoptosis proteins (cIAP) 1, cIAP2 and ML-IAP

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Xevinapant without active substance

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: cetuximab
Description: cetuximab

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cetuximab
Description: cetuximab

Intervention type: RADIATION
Group type: PLACEBO_COMPARATOR
Intervention: IMRT
Description: IMRT (69.96 Gy in 33 fractions, 2.12 Gy/fraction)

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: IMRT
Description: IMRT (69.96 Gy in 33 fractions, 2.12 Gy/fraction)
Study: NCT06792721

Intervention type: GENETIC
Intervention: Mutation Burden cfMB analysis
Description: Blood samples will be collected (one time only)

Intervention type: GENETIC
Intervention: Mutation Burden cfMB analysis
Description: Blood samples will be collected (one time only)
Study: NCT06792890

Intervention type: OTHER
Group type: OTHER
Intervention: Use Nabla AI Scribe tool provided
Description: AI Scribe technologies capture physician-patient conversations to create a transcript, then summarize the transcript in the form of a clinical notes. These tools are integrated into the EHR and automatically adds the generated text to the provider note. All physicians must inform patients about the recording and obtain their verbal consent, and instances of patients declining to consent are tracked.~Nabla leverages its proprietary speech-to-text to transform the conversation into a written context, combined with HIPAA compliant Large Language Models (LLM) like Azure OpenAI's GPT-4. Nabla does not store any audio.

Intervention type: OTHER
Group type: OTHER
Intervention: Use AI Scribe tool provided by Vendor B
Description: AI Scribe technologies capture physician-patient conversations to create a transcript, then summarize the transcript in the form of a clinical notes. These tools are integrated into the EHR and automatically adds the generated text to the provider note. All physicians must inform patients about the recording and obtain their verbal consent, and instances of patients declining to consent are tracked.
Study: NCT06796179

Intervention type: OTHER
Intervention: Visible Light Exposure - Treated zones with sunscreen products
Description: The treated zones with sunscreen products were exposed to Visible Light to induce skin pigmentation (144 J/cm²), 15 to 30 minutes after application.

Intervention type: OTHER
Intervention: Visible Light Exposure - Treated zones with sunscreen products
Description: The treated zones with sunscreen products were exposed to Visible Light to induce skin pigmentation (144 J/cm²), 15 to 30 minutes after application.

Intervention type: OTHER
Intervention: Visible Light Exposure - Treated zones with sunscreen products
Description: The treated zones with sunscreen products were exposed to Visible Light to induce skin pigmentation (144 J/cm²), 15 to 30 minutes after application.

Intervention type: OTHER
Intervention: Visible Light Exposure - Treated zones with sunscreen products
Description: The treated zones with sunscreen products were exposed to Visible Light to induce skin pigmentation (144 J/cm²), 15 to 30 minutes after application.

Intervention type: OTHER
Intervention: Visible Light Exposure - Treated zones with sunscreen products
Description: The treated zones with sunscreen products were exposed to Visible Light to induce skin pigmentation (144 J/cm²), 15 to 30 minutes after application.

Intervention type: OTHER
Intervention: Visible Light Exposure - Treated zones with sunscreen products
Description: The treated zones with sunscreen products were exposed to Visible Light to induce skin pigmentation (144 J/cm²), 15 to 30 minutes after application.

Intervention type: OTHER
Intervention: Visible Light Exposure - Treated zones with sunscreen products
Description: The treated zones with sunscreen products were exposed to Visible Light to induce skin pigmentation (144 J/cm²), 15 to 30 minutes after application.

Intervention type: OTHER
Intervention: Visible Light Exposure - Untreated zone
Description: The untreated zone was exposed to Visible Light to induce skin pigmentation (144J/cm2), as the same time as the treated zones.
Study: NCT06797284

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial Magnetic Stimulation
Description: repetitive transcranial magnetic stimulation, transcranial direct current stimulation, daytime timed bright light exposure (10,000 lux of intense white light)
Study: NCT06792864

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: OsteoprintCR
Description: Hybrid technique of 3D printed bone matrix based on polycaprolactone with tricalcium beta phosphate

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: SMAR SET GMV Endurance Gentamicin
Description: Patient undergoing cranioplasty with conventional technique using polymethylmethylmethacrylate-based surgical cement brand SMAR SET GMV Endurance Gentamicin.
Study: NCT06796764

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: the COMBO Endoscopy Oropharyngeal Airway Group
Description: Using the COMBO Endoscopy Oropharyngeal Airway for oxygenation.

Intervention type: DEVICE
Group type: ACTIVE_COMPARATOR
Intervention: Regular Nasal Cannula
Description: Using regular nasal cannula for oxygenation.
Study: NCT06057623

Intervention type: OTHER
Intervention: Evaluation of central and peripheral neuromuscular fatigue
Description: To define peripheral and central component of fatigue, the investigators will test, before, during and after the fatigue task, the force produced during a Maximal Voluntary Contraction (MVC) and the force produced by the electrically evoked Resting Twitch (RT) produced, at rest, 5 seconds after the MVC.

Intervention type: OTHER
Intervention: Evaluation of central and peripheral neuromuscular fatigue
Description: To define peripheral and central component of fatigue, the investigators will test, before, during and after the fatigue task, the force produced during a Maximal Voluntary Contraction (MVC) and the force produced by the electrically evoked Resting Twitch (RT) produced, at rest, 5 seconds after the MVC.
Study: NCT06794242

Intervention type: OTHER
Intervention: Body representation
Description: All the participants (controls and patients) in the study will follow the same experimental procedure, which consists of a single virtual reality session involving the estimation of leg length and an object.

Intervention type: OTHER
Intervention: Body representation
Description: All the participants (controls and patients) in the study will follow the same experimental procedure, which consists of a single virtual reality session involving the estimation of leg length and an object.
Study: NCT06795152

Intervention type: OTHER
Intervention: No intervention
Description: Observational. Natural history study.
Study: NCT06796452

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Ribs Mobilization
Description: Three sets of 6-8 repetitions in each session and conventional(Baseline) Physical therapy Treatment.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional treatment
Description: * Hot pack for 8 min~* Maitland Generalized Cervical Mobilizations (6-8 REPS,3 sets)~* Isometric Strengthening Exercise Patient will be in sitting position.Contraction will be held for 5 seconds/repetitions and repeated 10 times, with 3 seconds rest in between them.These exercises will be done for 2 sets with 1 to 2 minutes rest in between each set.~Flexion:Therapist will place his hand on the forehead of patient and the patient was asked to press the forehead in to the palms of the therapist in a nodding fashion.~Side Flexion:Therapist will place his one hand on the side of the patient's head and the patient will be asked to press the therapist hand in a side flexion fashion.~Extension:Therapist will place his one hand on the back of the patient's head, near the top of the head. The patient will be asked to press the head on the therapist hand.~Rotation:Therapist will place one hand against region just superior and lateral to eye.Patient will be ask to turn the head to look own shoulder
Study: NCT06794515

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: cGMP-AAs alone (20 g of protein equivalent)
Description: cGMP-AAs alone (20 g of protein equivalent)

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: cGMP-AAs (20 g of protein equivalent) + 50 g of low-protein bread + 160 g of unpeeled apple
Description: cGMP-AAs (20 g of protein equivalent) + 50 g of low-protein bread + 160 g of unpeeled apple

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: cGMP-AAs (20 g of protein equivalent) + 50 g of low-protein bread + 10 g of olive oil
Description: cGMP-AAs (20 g of protein equivalent) + 50 g of low-protein bread + 10 g of olive oil
Study: NCT06794359

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Minimally Invasive Coronary Artery Bypass Grafting
Description: Minimally Invasive Coronary Artery Bypass Grafting will be accomplished by complete revascularization of all previous defined coronary targets through left anterior thoracotomy. On or off pump approach will be determined by the surgeon. For on pump cases, femoral canulation will be performed and aortic cross clamp will be used. Off Pump cases will be performed using Medtronic Octopus and Starfish NS. Intra operative Transit time flow measurement will be performed in all cases.

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Coronary artery bypass surgery
Description: Procedure: Conventional Coronary Artery Bypass Grafting will be accomplished by complete revascularization of all previous defined coronary targets through classical total sternotomy. On or off pump approach will be determined by the surgeon. Intra operative Transit time flow measurement will be performed in all cases.
Study: NCT06797752

Intervention type: DEVICE
Intervention: OCTA Scan
Description: Optical Coherence Tomography Angiography before and after receiving the stellate ganglion nerve block.
Study: NCT06795815

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Go Wish Game
Description: The Go Wish Game (GWG) provides a simple tool, composed by 35 cards to identify individual priorities. GWG is welcomed as a first step in clarifying values and personal thoughts linked to the end of life. The GWG discussion will be divided into two meetings. During the first one, the physician instructs the patients and their caregivers on how the GWG works. The patient will be invited to divide the cards into three sets, labeling the content of the cards within each set as: Very important;more or less important and not important.~This will be the base for the second meeting. During the second meeting - scheduled within one week - each category of card sets will be discussed with patients and their caregivers. The identification of the most relevant wishes or priorities of each patient will be incorporated into the individual therapeutic plan and the patient will be offered the option to make a formal ACP in the following 4 weeks.
Study: NCT06794385

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: dinoprostone vaginal delivery system
Description: Pregnant women in this group will receive a vaginal delivery system containing 10 mg of dinoprostone for labor induction.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: low dose peroral misoprostol
Description: Participants will be induced with a low-dose oral formulation of misoprostol, administered per protocol at 25 mcg every 2 hours
Study: NCT06793137

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Metronidazole
Description: This intervention involves administering the oral antibiotic metronidazole during the first seven days of radiotherapy for patients with locally advanced rectal adenocarcinoma who are undergoing total neoadjuvant treatment. Metronidazole is considered a safe medication, with a very low risk of adverse effects. It is commonly used to treat infections caused by anaerobic bacteria that are part of the intestinal microbiota. Additionally, it is well established that certain genera of anaerobic bacteria are linked to a poorer response to treatment.
Study: NCT06793332

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ivonescimab Combined With TROP2 ADC
Description: Ivonescimab: 20 mg/kg, ivggt, day 1, every 3 weeks; Sacituzumab govitecan: 10 mg/kg, ivggt, day 1 and day 8, every 3 weeks;
Study: NCT06796309

Intervention type: OTHER
Group type: OTHER
Intervention: Trak Telerehabilitation Platform
Description: The exercise protocol designed is carried out through TRAK, the digital rehabilitation tool.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Trak Telerehabilitation Platform
Description: The exercise protocol designed is carried out through TRAK, the digital rehabilitation tool.

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Rehabilitation Program
Description: Exercise protocol with the methodology of conventional clinical practice.
Study: NCT06794593

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Camostat Mesylate
Description: Oral Camostat Mesylate 200 mg x 3 daily for 4 days.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Camostat Mesylate
Description: Oral Camostat Mesylate 200 mg x 3 daily for 4 days.
Study: NCT06795178

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FP-014
Description: 11.25 mg in a prefilled, ready-to-use, long-acting formulation
Study: NCT06070298

Intervention type: DIAGNOSTIC_TEST
Intervention: Computer algorithms
Description: Collection of lightweight computer algorithms called ausculto™ that is designed to perform real-time heart sound analysis to detect heart murmur.

Intervention type: DIAGNOSTIC_TEST
Intervention: Computer algorithms
Description: Collection of lightweight computer algorithms called ausculto™ that is designed to perform real-time heart sound analysis to detect heart murmur.
Study: NCT06796478

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Tailored Egoscue Excercises
Description: A. Elbow curls on the wall with abduction B. Elbow curls on the wall with adduction C. Overhead extension D. Open Up arm and chest E. Upper spinal twist. F. Spinal Twist G. Pelvic tilts H. Static back alone and static back with breathing I. Static wall. J. Air Bench Abdominal contraction in the static back position. K. Resisted Abduction L. Abductor press M. Supine groin progression

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Core stabilization excercises
Description: A. Cat Pose \& Camel pose B. Pelvic tilt C. Hip flexor stretches D. Hamstring stretches E. Piriformis stretch F. Prone on elbow
Study: NCT06793761

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Pembrolizumab 200mg, IV, 3 cycles

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Pembrolizumab 200mg, IV, 3 cycles

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: cisplatin 75mg/m2, IV, 3 cycles

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: cisplatin 75mg/m2, IV, 3 cycles

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nab-paclitaxel
Description: Nab-paclitaxel 260mg, IV, 3 cycles

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Nab-paclitaxel
Description: Nab-paclitaxel 260mg, IV, 3 cycles
Study: NCT06793683

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bladder chemodenervation (Botox)
Description: BoNT-A (Botox) 200 U will be injected into the detrusor (bladder wall muscle).

Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Bladder Sham (Saline) Injection Procedure
Description: 20mL placebo (saline only), will be injected into the detrusor (bladder wall muscle).